Cargando…

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

Detalles Bibliográficos
Autores principales:	Chen, Yan‐Xing, Wang, Zi‐Xian, Yuan, Shu‐Qiang, Jiang, Teng‐Jia, Huang, You‐Sheng, Xu, Rui‐Hua, Wang, Feng, Zhao, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473642/ https://www.ncbi.nlm.nih.gov/pubmed/34586735 http://dx.doi.org/10.1002/ctm2.524

Ejemplares similares

Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1
por: Mur, Pilar, et al.
Publicado: (2023)

Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps
por: Elsayed, Fadwa A., et al.
Publicado: (2019)

POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East
por: Siraj, Abdul K., et al.
Publicado: (2020)

POLE/POLD1 mutation and tumor immunotherapy
por: Ma, Xiaoting, et al.
Publicado: (2022)

Non-Exonuclease Domain POLE Mutations Associated with Immunotherapy Benefit
por: Dong, Sharlene, et al.
Publicado: (2022)

Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
por: Palles, Claire, et al.
Publicado: (2012)

Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation
por: Wen, Lei, et al.
Publicado: (2022)

POLE exonuclease domain mutations in endometrial carcinoma: a case report
por: Pasciuto, Maria Paola, et al.
Publicado: (2023)

Role of POLE and POLD1 in familial cancer
por: Mur, Pilar, et al.
Publicado: (2020)

POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer
por: Siraj, Abdul K, et al.
Publicado: (2020)

Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region
por: Siraj, Abdul K., et al.
Publicado: (2019)

Risk of colorectal cancer for carriers of a germline mutation in POLE or POLD1
por: Buchanan, Daniel D., et al.
Publicado: (2017)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

Detection of Allelic Variants of The POLE and POLD1 Genes in Colorectal Cancer Patients
por: Pätzold, LA, et al.
Publicado: (2017)

Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer
por: Fang, Hu, et al.
Publicado: (2020)

First description of ultramutated endometrial cancer caused by germline loss-of-function and somatic exonuclease domain mutations in POLE gene
por: Rosa, Reginaldo Cruz Alves, et al.
Publicado: (2020)

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor
por: He, Junjun, et al.
Publicado: (2021)

A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report
por: Cui, Jiantao, et al.
Publicado: (2023)

Integrating POLE / POLD1 mutated for immunotherapy treatment planning of advanced stage non‐small cell lung cancer
por: Zheng, Shuhua, et al.
Publicado: (2023)

POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer
por: Esteban-Jurado, Clara, et al.
Publicado: (2017)

Roles of human POLD1 and POLD3 in genome stability
por: Tumini, Emanuela, et al.
Publicado: (2016)

Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers
por: Jansen, Anne ML, et al.
Publicado: (2016)

POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance
por: Bellido, Fernando, et al.
Publicado: (2016)

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
por: Temko, Daniel, et al.
Publicado: (2018)

Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain
por: Huang, Fangjin, et al.
Publicado: (2020)

Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer
por: Tian, Wenjuan, et al.
Publicado: (2022)

Immune checkpoint inhibitor in recurrent hypermutated glioblastoma with POLE mutation
por: Sathornsumetee, Sith, et al.
Publicado: (2021)

Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families
por: Weber, Christine A. M., et al.
Publicado: (2023)

Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort
por: Khan, Nikhat, et al.
Publicado: (2017)

DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer
por: Church, David N., et al.
Publicado: (2013)

Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population
por: Yao, Jianfei, et al.
Publicado: (2019)

A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
por: Tang, Hui, et al.
Publicado: (2022)

CTCF Mediates Replicative Senescence Through POLD1
por: Hou, Yuli, et al.
Publicado: (2021)

Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers
por: Garmezy, Benjamin, et al.
Publicado: (2022)

Prospects of POLD1 in Human Cancers: A Review
por: Gola, Michał, et al.
Publicado: (2023)

Rapid genome editing by CRISPR-Cas9-POLD3 fusion
por: Reint, Ganna, et al.
Publicado: (2021)

Preliminary study on the function of the POLD1 (CDC2) EXON2 c.56G>A mutation
por: Liu, Jing, et al.
Publicado: (2020)

A hypomorphic mutation in Pold1 disrupts the coordination of embryo size expansion and morphogenesis during gastrulation
por: Chen, Tingxu, et al.
Publicado: (2022)

Human POLD1 modulates cell cycle progression and DNA damage repair
por: Song, Jing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qj79dljdnehigb813k5278ss8h